Kids who took more antibiotics between late childhood and their early twenties were far more likely to have irritable bowel syndrome by age 24, a new study finds.
Quick Take
- A Swedish study of 2,853 young adults found antibiotic use tied to a 50% higher chance of having IBS by age 24.
- Risk climbed with every added prescription, topping out at nearly double the odds for six or more courses.
- Two antibiotic types, tetracyclines and cephalosporins, stood out even after researchers adjusted for other factors.
- Researchers stress the study shows a link, not proof that antibiotics cause IBS.
What The Swedish Study Actually Found
Researchers tracked participants in Sweden’s BAMSE birth cohort, pulling antibiotic prescription records starting in 2005, when the kids were 9 to 11 years old, up until one year before they were checked for IBS at age 24. Among those with IBS, 87.8% had taken antibiotics during that stretch. Among those without IBS, the number was 80.2%. After adjusting for sex and family income, antibiotic-exposed participants had 1.5 times the odds of having IBS.
The pattern did not stop at a simple yes-or-no comparison. Researchers found a clear dose-response relationship. One or two antibiotic prescriptions bumped the odds up by 30%. Three to five prescriptions pushed it to 60% higher. Six or more prescriptions nearly doubled the odds, landing at 70% higher than no antibiotics at all. That steady climb, with a statistical trend value below 0.001, is the kind of pattern that gets a researcher’s attention.
Which Drug Types Raised The Most Concern
Not every antibiotic carried the same weight in the findings. After adjusting for sex and family socioeconomic status, two specific classes, tetracyclines and cephalosporins, remained significantly tied to higher IBS odds. Other antibiotic types did not hold up the same way once those adjustments were made. That detail matters because it suggests the story may not be about antibiotics broadly so much as about certain drug families and how they interact with the gut.
The idea that early antibiotics could mess with long-term gut health is not new. A 2021 systematic review found strong evidence connecting early-life antibiotic use with some childhood gastrointestinal diseases. A separate 2023 review pointed out that antibiotics taken during pregnancy or the newborn period can disrupt gut bacteria in ways that look a lot like what shows up in IBS patients. None of that proves this specific study’s conclusion, but it gives the finding a plausible mechanism rather than leaving it as a random statistical blip.
Why Doctors Still Call This A Link, Not A Cause
The study’s own summary is blunt: this research shows an association, not proof that antibiotics cause IBS. The confidence interval around the main 1.5-times odds estimate stretched from 1.0 to 2.2, meaning the true effect could be barely above zero or could be considerably stronger. That kind of spread is common in observational research, and it is exactly why scientists resist calling a single study the final word.
There is also a timing wrinkle worth noting. The exposure window ran from ages 9 to 11 through early adulthood, not from infancy. So this study cannot say whether the real driver was early childhood antibiotics, teenage prescriptions, or some combination layered over years. Sorting that out would require breaking the data into narrower age bands, something future research could tackle with the same prescription registry.
Putting The Numbers In A Bigger Context
Antibiotics are already common in childhood medicine, prescribed in roughly 18% to 36% of acute pediatric visits depending on the practice, with broad-spectrum drugs making up a big share of those orders. That widespread use is part of why researchers have to be careful. When almost everyone has been exposed to something, teasing out its specific effect from the dozens of illnesses, family situations, and healthcare habits tangled up with it becomes a genuine challenge.
Antibiotics have saved millions of lives by turning dangerous bacterial infections into easily treatable illnesses, yet scientists are discovering that repeated exposure during our growing years can leave a lasting mark on our digestive health. New research presented at United… pic.twitter.com/4wMSzZTNUq
— Science & Nature (@ScienceIsNew) October 19, 2026
Related research on inflammatory bowel disease, a different but sometimes confused condition, found a similar pattern. A pooled analysis of two Scandinavian birth cohorts linked first-year antibiotic use to a 33% higher risk of later IBD, even after accounting for the infections that prompted the prescriptions. IBD and IBS are not the same illness, but the overlapping signal across both conditions adds weight to the broader theory that early gut bacteria disruption has lasting consequences. For parents and adults managing recurring prescriptions, this study is a reason to ask more questions, not to panic over every round of antibiotics a child needed for a real infection.
Sources:
youtube.com, pubmed.ncbi.nlm.nih.gov, usnews.com, tandfonline.com
